GT Medical Technologies raises a $16,000,000 series B round from BlueStone Venture Partners, MVM and MedTech Venture Partners.
GT Medical Technologies raises a $10,000,000 series A round from BlueStone Venture Partners and MedTech Venture Partners.
Documentaries, videos and podcasts
May 25, 2021
Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with GT Medical Technologies, Inc., to develop Tumor Treating Fields (TTFields) together with GT Medical Technologies' GammaTile Surgically Targeted Radiation Therapy (STaRT) for treatment of recurrent glioblastoma (GBM). Novocure's TTFields are electric fields that disrupt cancer cell division.
November 23, 2020
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.